Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CHF Solutions, a manufacturer of medical devices for cardiac care, has finalized an agreement with Premier Purchasing Partners, a healthcare group purchasing organization in the US.
Subscribe to our email newsletter
Under this agreement, a new category, Aquapheresis therapy products, has been created for CHF Solutions’s products, which are immediately available to the 2,000 hospitals and 53,000-plus other healthcare sites of the Premier Healthcare Alliance.
CHF Solutions’s Aquapheresis therapy is a method to safely and effectively remove the excess salt and water in patients with fluid overload. Currently, Aquapheresis is available at more than 250 medical centers and outpatient clinics worldwide.
Kelly Hofstatter, clinical director of cardiovascular services at Premier, said: “Our Purchasing Partners sourcing team continually seeks innovative new products for member agreements to accelerate clinical and financial performance. We believe that Aquapheresis therapy can help do just that.”